Celularity (CELU) EBT Margin (2020 - 2025)
Celularity's (CELU) quarterly EBT Margin came in at 593.54% in Q4 2025, up 133858.0% year-over-year from N/an in Q4 2024, and down 35.91% quarter-over-quarter from 436.71% in Q3 2025.
Powered by 
Analysis
Celularity (CELU) EBT Margin (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported EBT Margin for 6 consecutive years, with 593.54% the latest figure, recorded in Q4 2025.
- On a quarterly basis, EBT Margin rose 133858.0% year-over-year to 593.54% in Q4 2025; TTM through Dec 2025 was 345.44%, a 18802.0% decrease from a year earlier, with the FY2025 full-year figure at 345.44%, down 23866.0% from the prior year.
- EBT Margin was 593.54% for Q4 2025 at Celularity, down from 436.71% in the prior quarter.
- Over five years, EBT Margin peaked at 1267.03% in Q2 2022 and troughed at 3065.38% in Q1 2021.
- A 5-year average of 668.92% and a median of 300.36% in 2024 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin jumped 328383 bps in 2022 and plunged 289906 bps in 2023, its largest moves.
- Over 5 years, EBT Margin stood at 82.78% in 2021, then surged by 815 bps to 592.08% in 2022, then tumbled by 87 bps to 78.91% in 2023, then tumbled by 2549 bps to 1932.12% in 2024, then jumped by 69 bps to 593.54% in 2025.
- The last three EBT Margin figures came in at 593.54% (Q4 2025), 436.71% (Q3 2025), and 427.55% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | 55.43% |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | -885.91% |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | -49.02% |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 14.32% |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | -1,356.24% |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | -24,299.18% |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 36.51% |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | -0.44% |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 2.88% |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | -593.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -593.54% |
| Sep 30, 2025 | -436.71% |
| Jun 30, 2025 | -427.55% |
| Mar 31, 2025 | -172.89% |
| Dec 31, 2024 | -1,932.12% |
| Sep 30, 2024 | -173.17% |
| Jun 30, 2024 | -53.57% |
| Mar 31, 2024 | -149.94% |
| Dec 31, 2023 | 78.91% |
| Sep 30, 2023 | -2,479.56% |
| Jun 30, 2023 | -1,632.03% |
| Mar 31, 2023 | -1,626.86% |
| Dec 31, 2022 | 592.08% |
| Sep 30, 2022 | 115.65% |
| Jun 30, 2022 | 1,267.03% |
| Mar 31, 2022 | -1,059.26% |
| Dec 31, 2021 | -82.78% |
| Sep 30, 2021 | 470.14% |
| Jun 30, 2021 | -2,016.80% |
| Mar 31, 2021 | -3,065.38% |